{
  "ticker": "ILA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964934",
  "id": "02964934",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250702",
  "time": "0945",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06lcl53m4n7c8j.pdf",
  "summary": "### Summary of ASX Announcement:  \n\n- **Appointment of Jason Carroll as Non-Executive Chairman** (effective 2 July 2025)  \n  - Significant pharmaceutical industry experience (Johnson & Johnson, Janssen, iNova).  \n  - Expertise in R&D, corporate strategy, and Southeast Asian market expansion.  \n  - Substantial shareholder in Island Pharmaceuticals, aligning with dengue fever drug development focus.  \n  - Continues as CEO of Tryp Therapeutics (ASX: TYP).  \n\n- **Phil Lynch steps down as Chairman** (no material impact disclosed).  \n\n**No material trading or capital markets information identified.**  \n*(Note: Board changes alone are not typically material for trading decisions unless accompanied by strategic shifts or capital structure impacts.)*",
  "usage": {
    "prompt_tokens": 1301,
    "completion_tokens": 156,
    "total_tokens": 1457,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T00:01:30.624978"
}